Cargando…

Estrogen Receptor Silencing Induces Epithelial to Mesenchymal Transition in Human Breast Cancer Cells

We propose the hypothesis that loss of estrogen receptor function which leads to endocrine resistance in breast cancer, also results in trans-differentiation from an epithelial to a mesenchymal phenotype that is responsible for increased aggressiveness and metastatic propensity. siRNA mediated silen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al Saleh, Sanaa, Al Mulla, Fahd, Luqmani, Yunus A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119661/ https://www.ncbi.nlm.nih.gov/pubmed/21713035 http://dx.doi.org/10.1371/journal.pone.0020610

Ejemplares similares

Extracellular Alkaline pH Leads to Increased Metastatic Potential of Estrogen Receptor Silenced Endocrine Resistant Breast Cancer Cells
por: Khajah, Maitham A., et al.
Publicado: (2013)

PAC down-regulates estrogen receptor alpha and suppresses epithelial-to-mesenchymal transition in breast cancer cells
por: Al-Howail, Huda A., et al.
Publicado: (2016)

Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer
por: Di Zazzo, Erika, et al.
Publicado: (2019)

Differential Effect of Growth Factors on Invasion and Proliferation of Endocrine Resistant Breast Cancer Cells
por: Khajah, Maitham A., et al.
Publicado: (2012)

Markers of epithelial-mesenchymal transition in an experimental breast cancer model induced by organophosphorous pesticides and estrogen
por: Calaf, Gloria M., et al.
Publicado: (2020)

Silencing of BAG3 inhibits the epithelial-mesenchymal transition in human cervical cancer
por: Song, Fei, et al.
Publicado: (2017)

Silver Nanoparticles Modulate the Epithelial-to-Mesenchymal Transition in Estrogen-Dependent Breast Cancer Cells In Vitro
por: Rakowski, Michał, et al.
Publicado: (2021)

Modulatory effect of aquaporin 5 on estrogen-induced epithelial-mesenchymal transition in prostate epithelial cells
por: Fan, Yu, et al.
Publicado: (2021)

Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells
por: YAO-BORENGASSER, AIWEI, et al.
Publicado: (2015)

Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer
por: Yoriki, Kaori, et al.
Publicado: (2019)

PTTG2 silencing results in induction of epithelial-to-mesenchymal transition and apoptosis
por: Méndez-Vidal, C, et al.
Publicado: (2013)

Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells
por: Zhao, Xianqi, et al.
Publicado: (2015)

TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets
por: Wong, Kah Keng, et al.
Publicado: (2020)

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
por: Al-Khadairi, Ghaneya, et al.
Publicado: (2019)

MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells
por: Yin, Kai, et al.
Publicado: (2016)

Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition
por: Karamanou, Konstantina, et al.
Publicado: (2017)

Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrence
por: Aouad, Patrick, et al.
Publicado: (2022)

HPIP Silencing Prevents Epithelial–Mesenchymal Transition Induced by TGF-β1 in Human Ovarian Cancer Cells
por: Zhang, Guo-ying, et al.
Publicado: (2016)

Silencing Snail Reverses Epithelial-Mesenchymal Transition and Increases Radiosensitivity in Hypopharyngeal Carcinoma
por: Wang, HaiYan, et al.
Publicado: (2020)

Epithelial to mesenchymal transition and breast cancer
por: Tomaskovic-Crook, Eva, et al.
Publicado: (2009)

Epithelial-Mesenchymal Transition and Breast Cancer
por: Wu, Yanyuan, et al.
Publicado: (2016)

Epigenetic Silencing of HER2 Expression during Epithelial-Mesenchymal Transition Leads to Trastuzumab Resistance in Breast Cancer
por: Nami, Babak, et al.
Publicado: (2021)

FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer
por: Malgundkar, Shika Hanif, et al.
Publicado: (2020)

Role of estrogen in lung cancer based on the estrogen receptor-epithelial mesenchymal transduction signaling pathways
por: Zhao, Xiao-zhen, et al.
Publicado: (2015)

Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis
por: Qureshi, Rehana, et al.
Publicado: (2022)

The Effect of Hydroxytyrosol in Type II Epithelial-Mesenchymal Transition in Human Skin Wound Healing
por: Batarfi, Wafa Ali, et al.
Publicado: (2023)

Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor
por: Senol, Serkan, et al.
Publicado: (2016)

MicroRNA expression profiling of endocrine sensitive and resistant breast cancer cell lines
por: Khajah, Maitham A., et al.
Publicado: (2022)

Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer
por: Radisky, Evette S., et al.
Publicado: (2010)

Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial–mesenchymal transition in triple‐negative breast cancer
por: Lv, Zhi‐Dong, et al.
Publicado: (2016)

MicroRNA-195 inhibits epithelial-mesenchymal transition by targeting G protein-coupled estrogen receptor 1 in endometrial carcinoma
por: Deng, Junfeng, et al.
Publicado: (2019)

A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal Transition
por: Banerjee, Ananya, et al.
Publicado: (2022)

Epithelial to Mesenchymal Transition in a Clinical Perspective
por: Pasquier, Jennifer, et al.
Publicado: (2015)

Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis
por: Aversa, I., et al.
Publicado: (2017)

Repression of Smad3 by silencing Robo1 attenuates epithelial-mesenchymal transition in tracheobronchial stenosis
por: He, Chunyan, et al.
Publicado: (2023)

Toll-like receptor 4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women
por: Semlali, Abdelhabib, et al.
Publicado: (2017)

Paeoniflorin prevents hypoxia-induced epithelial–mesenchymal transition in human breast cancer cells
por: Zhou, Zhenyu, et al.
Publicado: (2016)

Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells
por: Castillo, Lilian Fedra, et al.
Publicado: (2016)

3,3′-Diindolylmethane Suppressed Cyprodinil-Induced Epithelial-Mesenchymal Transition and Metastatic-Related Behaviors of Human Endometrial Ishikawa Cells via an Estrogen Receptor-Dependent Pathway
por: Kim, Bo-Gyoung, et al.
Publicado: (2018)

Transient Receptor Potential Channels in the Epithelial-to-Mesenchymal Transition
por: Van den Eynde, Charlotte, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_293at5ch3lscds8fsl36golot1